Tradestie Institutional Equity Comparison Engine

VOR vs PGEN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PGEN Overall Edge

PGEN Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Precigen, Inc. Common Stock (PGEN) driven by superior Valuation, Growth & Margin while VOR counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, VOR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus PGEN at 7.3x Forward P/E and 21.4% operating margin (+2437.6% YoY). In options structure, VOR sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against PGEN sits in BREAKDOWN (11th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner PGEN
VOR N/M vs PGEN 7.3x Fwd P/E
Growth & Margin Winner PGEN
Op Margin 0.0% vs 21.4% ยท YoY +0.0% vs +2437.6%
Momentum & Technical Winner VOR
1Y +94.6% vs +11.4% ยท 52W Pos 64% vs 21%
Options & Structure Winner VOR
CONSOLIDATION (6th %ile IV) vs BREAKDOWN (11th %ile IV)
VOR NASDAQ
Vor Biopharma Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$18.97
-2.32% 1D
Market Cap $1.2B
1M Return +5.21%
1Y Return +94.56%
Forward P/E N/M
Unified AI Score
57.8 / 100 HOLD
Tech 50.0 Fund 55.0 Flow 66.0 Mom 50.0
PGEN NASDAQ
Precigen, Inc. Common Stock
Pharmaceutical Preparations
$4.30
-5.29% 1D
Market Cap $1.7B
1M Return -32.65%
1Y Return +11.4%
Forward P/E 7.3x
Unified AI Score
60.2 / 100 BUY
Tech 63.0 Fund 65.0 Flow 67.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VOR +94.56% PGEN +11.4% Spread: +83.16 pp (VOR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
VOR TTM Op. Margin: 0.0% PGEN TTM Op. Margin: 21.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VOR vs PGEN. Trailing 12-month operating profitability (VOR 0.0% vs PGEN 21.4%) and valuation multiples (VOR N/M vs PGEN 7.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VOR (3) vs PGEN (7)
Institutional Metric VOR PGEN Criterion Row Winner
Market Capitalization Scale $1.2B $1.7B Larger Scale PGEN
Trailing P/E Ratio Valuation 0.1x 42.4x Lower Multiple VOR
Forward P/E Ratio Valuation N/M 7.3x Lower Multiple PGEN
Revenue Growth (YoY) Growth +0.0% +2437.6% Higher Growth PGEN
Operating Margin (TTM) Profitability 0.0% 21.4% Higher Margin PGEN
Net Profit Margin Profitability 0.0% 15.6% Higher Margin PGEN
Return on Equity (ROE) Capital Efficiency -125.4% 38.8% Higher ROE PGEN
52-Week Range Position Momentum 64% ($6โ€“$26) 21% ($3โ€“$9) Stronger Trend VOR
Beta / 30D Volatility Risk Regime 1.90ฮฒ ยท 61% Vol 1.74ฮฒ ยท 122% Vol Lower Realized Risk VOR
Unified Institutional Score Composite Signal 57.8 / 100 (HOLD) 60.2 / 100 (BUY) Higher Composite PGEN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VOR vs PGEN Buy Guide
VOR CONSOLIDATION
52d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live VOR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PGEN BREAKDOWN
61d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live PGEN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VOR nor PGEN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.